Jw. Koten et al., THE DIFFERENCE BETWEEN BENIGN AND MALIGNANT-TUMORS EXPLAINED WITH THE4-MUTATION PARADIGM FOR CARCINOGENESIS, Anticancer research, 13(4), 1993, pp. 1179-1182
In recent years a 4-mutation paradigm for carcinogenesis was developed
for mutations in tumour suppressor genes. The major tenet of this par
adigm is that transformation of a normal cell into a malignant cell is
the result of an accumulation of a set of 4 specific cancer mutations
. In this paper we show that this paradigm can explain the characteris
tic differences between benign and malignant tumours. We surmise that
benign tumour cells are due to 2 or 3 specific ancer mutations, wherea
s malignant tumour cells contain 4 specific cancer mutations and 1-3 t
umour progression mutations. The following characteristics, essential
for differentiating benign and malignant tumours, are explained by our
paradigm: (a) differentiation - anaplasia, (b) rate of growth, (c) en
capsulation -invasion, (d) metastasis, and (e) the differences in size
of benign epithelial and mesenchymal tumours and the relation between
tumour size and malignancy.